More antioxidants in sepsis: still paved with uncertainties.
Cross
Carroll E
CE
van Asbeck
B S
BS
Halliwell
Barry
B
D000111:Acetylcysteine / Q000627:therapeutic use*; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D003676:Deferoxamine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects; D012128:Respiratory Distress Syndrome / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D018805:Sepsis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D017262:Siderophores / Q000627:therapeutic use*
D017262:Siderophores; D003676:Deferoxamine; D000111:Acetylcysteine